When did Kangmei Pharmaceutical file for bankruptcy reorganization?

Kangmei Pharmaceutical Co., Ltd. was filed for bankruptcy and reorganization by Guangdong Jiedong Rural Commercial Bank Co., Ltd. on April 22, involving case number (202 1) Guangdong 52 Poshen 1.

According to the enterprise survey on May 10, Kangmei Pharmaceutical Co., Ltd. was applied for bankruptcy and reorganization by Guangdong Jiedong Rural Commercial Bank Co., Ltd. on April 22, involving the case number of (202 1) Guangdong 52 quite deep 1.

Enterprise survey shows that the company was established in June 1997, and its legal representative is Ma Xinggu. At present, the company has listed A shares on the risk warning board of Shanghai Stock Exchange, with a circulating market value of 965,438+26 million, and the company has been enforced by the court for three times.

Non-operating funds to be solved:

Yin Shi Finance and Economics reporter noted that as of 20 19, 12, 3 1, Puning Kangchun Pharmaceutical Co., Ltd. and Puning Du Kang Pharmaceutical Co., Ltd. actually controlled by Ma Xingtian occupied 948 1 100 million yuan (principal) of listed companies for non-operation.

According to the announcement, Ma Xingtian issued a debt repayment commitment letter to *ST Kangmei on June 17, 2020, promising to repay the debt in three phases: before June 65438+February 3 1 2020, the accumulated repayment amount to the company in cash should not be less than 10% of the total occupied funds, that is, 948 million yuan.

Before 20021,65438+2, 3 1, the accumulated repayment to the company in cash shall not be less than 40% of the total occupied funds, that is, 3.792 billion yuan; Before 65438+February 3, 20221,the company shall pay all the occupied funds and the interest calculated at the benchmark interest rate of bank loans for the same period in cash.

By June 5438+February 3, 20201day, Ma Xingtian had paid off 40 million yuan in cash through Shenzhen Boyi Investment Development Co., Ltd., which was far from the promised 948 million yuan.